Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 1
2016 1
2017 4
2018 5
2019 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy.
Iio E, Matsuura K, Shimada N, Atsukawa M, Itokawa N, Abe H, Kato K, Takaguchi K, Senoh T, Eguchi Y, Nomura H, Yoshizawa K, Kang JH, Matsui T, Hirashima N, Kusakabe A, Miyaki T, Fujiwara K, Matsunami K, Tsutsumi S, Iwakiri K, Tanaka Y. Iio E, et al. Among authors: matsunami k. J Gastroenterol. 2019 Apr;54(4):339-346. doi: 10.1007/s00535-018-1526-3. Epub 2018 Oct 31. J Gastroenterol. 2019. PMID: 30382363
Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA+-M2BP) in Chronic Hepatitis C with Advanced Fibrosis.
Inoue T, Tsuzuki Y, Iio E, Shinkai N, Matsunami K, Fujiwara K, Matsuura K, Nojiri S, Tanaka Y. Inoue T, et al. Among authors: matsunami k. Jpn J Infect Dis. 2018 May 24;71(3):177-183. doi: 10.7883/yoken.JJID.2017.459. Epub 2018 Feb 28. Jpn J Infect Dis. 2018. PMID: 29491234 Free article.
High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues.
Shinkai N, Nojima M, Iio E, Matsunami K, Toyoda H, Murakami S, Inoue T, Ogawa S, Kumada T, Tanaka Y. Shinkai N, et al. Among authors: matsunami k. J Gastroenterol. 2018 Jul;53(7):883-889. doi: 10.1007/s00535-017-1424-0. Epub 2017 Dec 29. J Gastroenterol. 2018. PMID: 29288305
Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy.
Iio E, Shimada N, Takaguchi K, Senoh T, Eguchi Y, Atsukawa M, Tsubota A, Abe H, Kato K, Kusakabe A, Miyaki T, Matsuura K, Matsunami K, Shinkai N, Fujiwara K, Nojiri S, Tanaka Y. Iio E, et al. Among authors: matsunami k. Hepatol Res. 2017 Nov;47(12):1308-1316. doi: 10.1111/hepr.12898. Epub 2017 May 6. Hepatol Res. 2017. PMID: 28332272
Validation of cross-genotype neutralization by hepatitis B virus-specific monoclonal antibodies by in vitro and in vivo infection.
Hamada-Tsutsumi S, Iio E, Watanabe T, Murakami S, Isogawa M, Iijima S, Inoue T, Matsunami K, Tajiri K, Ozawa T, Kishi H, Muraguchi A, Joh T, Tanaka Y. Hamada-Tsutsumi S, et al. Among authors: matsunami k. PLoS One. 2015 Feb 18;10(2):e0118062. doi: 10.1371/journal.pone.0118062. eCollection 2015. PLoS One. 2015. PMID: 25693196 Free PMC article.
Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
Matsunami K, Nishida N, Kaneko N, Ikeo K, Toyo-Oka L, Takeuchi H, Matsuura K, Tamori A, Nomura H, Yoshiji H, Imamura M, Masaki N, Hayakawa T, Ide T, Shimada N, Ikeda F, Hino K, Nishiguchi S, Okuse C, Nojiri S, Sawamoto K, Tokunaga K, Joh T, Tanaka Y. Matsunami K, et al. PLoS One. 2016 Oct 10;11(10):e0164418. doi: 10.1371/journal.pone.0164418. eCollection 2016. PLoS One. 2016. PMID: 27723809 Free PMC article. Clinical Trial.
11 results